Citigroup
ASLN

Citigroup’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Citigroup’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,250
Closed -$107K – 5899
2023
Q3 		$107K Hold
7,250
– – ﹤0.01% 3906
2023
Q2 		$212K Hold
7,250
– – ﹤0.01% 3871
2023
Q1 		$168K Hold
7,250
– – ﹤0.01% 3819
2022
Q4 		$104K Buy
+7,250
New +$140K ﹤0.01% 4007

Other funds holding ASLN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup's ASLN Position: Q4 2023 in Review

Citigroup sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q4 2023, closing a stake of 7,250 shares — an estimated $107K sold.

Citigroup first reported a position in ASLN in Q4 2022 and held it in 4 quarters. The position peaked at $212K in Q2 2023. 22 funds tracked by Wall St. Rank hold ASLN as of Q4 2023.

  • Citigroup reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Citigroup sold 7,250 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q4 2023, an estimated $107K.
  • Citigroup first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2022 and held it in 4 quarters.
  • Citigroup's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $212K in Q2 2023.
  • 22 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q4 2023.

Based on Citigroup's 13F filing for Q4 2023, filed 9 Feb 2024.